Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Extrapolating evidence of antiepileptic drug efficacy in adults to children ≥2 years of age with focal seizures: The case for disease similarity.

Pellock JM, Arzimanoglou A, D'Cruz O, Holmes GL, Nordli D, Shinnar S; Pediatric Epilepsy Academic Consortium for Extrapolation.

Epilepsia. 2017 Oct;58(10):1686-1696. doi: 10.1111/epi.13859. Epub 2017 Jul 29. Review.

2.

Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation.

Wadsworth I, Jaki T, Sills GJ, Appleton R, Cross JH, Marson AG, Martland T, McLellan A, Smith PE, Pellock JM, Hampson LV.

CNS Drugs. 2016 Nov;30(11):1011-1017. Review.

3.

Quantitative Evaluation of Medial Temporal Lobe Morphology in Children with Febrile Status Epilepticus: Results of the FEBSTAT Study.

McClelland AC, Gomes WA, Shinnar S, Hesdorffer DC, Bagiella E, Lewis DV, Bello JA, Chan S, MacFall J, Chen M, Pellock JM, Nordli DR Jr, Frank LM, Moshé SL, Shinnar RC, Sun S; FEBSTAT Study Team.

AJNR Am J Neuroradiol. 2016 Dec;37(12):2356-2362. Epub 2016 Sep 15.

4.

Risk factors for subsequent febrile seizures in the FEBSTAT study.

Hesdorffer DC, Shinnar S, Lax DN, Pellock JM, Nordli DR Jr, Seinfeld S, Gallentine W, Frank LM, Lewis DV, Shinnar RC, Bello JA, Chan S, Epstein LG, Moshé SL, Liu B, Sun S; FEBSTAT study team.

Epilepsia. 2016 Jul;57(7):1042-7. doi: 10.1111/epi.13418. Epub 2016 Jun 6.

5.

Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry.

Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Jul;60:174-180. doi: 10.1016/j.yebeh.2016.03.030. Epub 2016 May 18.

PMID:
27208827
6.
7.

Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin.

Krauss G, Faught E, Foroozan R, Pellock JM, Sergott RC, Shields WD, Ziemann A, Dribinsky Y, Lee D, Torri S, Othman F, Isojarvi J.

Epilepsy Behav. 2016 Mar;56:15-9. doi: 10.1016/j.yebeh.2015.12.004. Epub 2016 Jan 22.

PMID:
26807550
8.

Use of computer simulations to test the concept of dose forgiveness in the era of extended-release (XR) drugs.

Pellock JM, Brittain ST.

Epilepsy Behav. 2016 Feb;55:21-3. doi: 10.1016/j.yebeh.2015.11.029. Epub 2015 Dec 24.

9.

Epilepsy After Febrile Seizures: Twins Suggest Genetic Influence.

Seinfeld SA, Pellock JM, Kjeldsen MJ, Nakken KO, Corey LA.

Pediatr Neurol. 2016 Feb;55:14-6. doi: 10.1016/j.pediatrneurol.2015.10.008. Epub 2015 Oct 31.

10.

Prevalence of pediatric epilepsy in low-income rural Midwestern counties.

Hawley SR, Ablah E, Hesdorffer D, Pellock JM, Lindeman DP, Paschal AM, Thurman DJ, Liu Y, Warren MB, Schmitz T, Rogers A, St Romain T, Hauser WA; Prevalence of Epilepsy in Rural Kansas Study Group.

Epilepsy Behav. 2015 Dec;53:190-6. doi: 10.1016/j.yebeh.2015.09.014. Epub 2015 Nov 14.

PMID:
26588587
11.

Hippocampal Malrotation Is Associated With Prolonged Febrile Seizures: Results of the FEBSTAT Study.

Chan S, Bello JA, Shinnar S, Hesdorffer DC, Lewis DV, MacFall J, Shinnar RC, Gomes W, Litherland C, Xu Y, Nordli DR, Pellock JM, Frank LM, Moshé SL, Sun S; FEBSTAT Study Team.

AJR Am J Roentgenol. 2015 Nov;205(5):1068-74. doi: 10.2214/AJR.14.13330.

12.

In response: Lennox-Gastaut syndrome may be a curable, reversible epileptic encephalopathy.

Pellock JM, Wheless JW, Douglass LM.

Epilepsia. 2015 Mar;56(3):500-1. doi: 10.1111/epi.12915. No abstract available.

13.

Is there a need for further trials for the treatment of prolonged seizures?

Pellock JM, Seinfeld S.

Epileptic Disord. 2014 Oct;16 Spec No 1:S103-7. doi: 10.1684/epd.2014.0693. Review.

PMID:
25323680
14.

Introduction: Recommendations regarding management of patients with Lennox-Gastaut syndrome.

Pellock JM, Wheless JW.

Epilepsia. 2014 Sep;55 Suppl 4:1-3. doi: 10.1111/epi.12661. No abstract available.

15.

Emergency management of febrile status epilepticus: results of the FEBSTAT study.

Seinfeld S, Shinnar S, Sun S, Hesdorffer DC, Deng X, Shinnar RC, O'Hara K, Nordli DR Jr, Frank LM, Gallentine W, Moshé SL, Pellock JM; FEBSTAT study team.

Epilepsia. 2014 Mar;55(3):388-95. doi: 10.1111/epi.12526. Epub 2014 Feb 6.

16.

Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.

Lewis DV, Shinnar S, Hesdorffer DC, Bagiella E, Bello JA, Chan S, Xu Y, MacFall J, Gomes WA, Moshé SL, Mathern GW, Pellock JM, Nordli DR Jr, Frank LM, Provenzale J, Shinnar RC, Epstein LG, Masur D, Litherland C, Sun S; FEBSTAT Study Team.

Ann Neurol. 2014 Feb;75(2):178-85. doi: 10.1002/ana.24081. Epub 2014 Mar 1.

17.

Recent Research on Febrile Seizures: A Review.

Syndi Seinfeld D, Pellock JM.

J Neurol Neurophysiol. 2013 Sep 25;4(165). pii: 19519.

18.

Risk factors for febrile status epilepticus: a case-control study.

Hesdorffer DC, Shinnar S, Lewis DV, Nordli DR Jr, Pellock JM, Moshé SL, Shinnar RC, Litherland C, Bagiella E, Frank LM, Bello JA, Chan S, Masur D, Macfall J, Sun S; Consequences of Prolonged Febrile Seizures in Childhood (FEBSTAT) Study Team.

J Pediatr. 2013 Oct;163(4):1147-51.e1. doi: 10.1016/j.jpeds.2013.05.038. Epub 2013 Jul 1.

19.

Acute EEG findings in children with febrile status epilepticus: results of the FEBSTAT study.

Nordli DR Jr, Moshé SL, Shinnar S, Hesdorffer DC, Sogawa Y, Pellock JM, Lewis DV, Frank LM, Shinnar RC, Sun S; FEBSTAT Study Team.

Neurology. 2012 Nov 27;79(22):2180-6. doi: 10.1212/WNL.0b013e3182759766. Epub 2012 Nov 7.

20.

Cerebrospinal fluid findings in children with fever-associated status epilepticus: results of the consequences of prolonged febrile seizures (FEBSTAT) study.

Frank LM, Shinnar S, Hesdorffer DC, Shinnar RC, Pellock JM, Gallentine W, Nordli DR Jr, Epstein LG, Moshé SL, Lewis DV, Sun S; FEBSTAT Study Team.

J Pediatr. 2012 Dec;161(6):1169-71. doi: 10.1016/j.jpeds.2012.08.008. Epub 2012 Sep 14.

21.

Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review.

Pellock JM, Carman WJ, Thyagarajan V, Daniels T, Morris DL, D'Cruz O.

Neurology. 2012 Oct 2;79(14):1482-9. doi: 10.1212/WNL.0b013e31826d5ec0. Epub 2012 Sep 5. Review.

22.

Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study.

Epstein LG, Shinnar S, Hesdorffer DC, Nordli DR, Hamidullah A, Benn EK, Pellock JM, Frank LM, Lewis DV, Moshe SL, Shinnar RC, Sun S; FEBSTAT study team.

Epilepsia. 2012 Sep;53(9):1481-8. doi: 10.1111/j.1528-1167.2012.03542.x. Epub 2012 Jun 14.

23.

Age-related epileptic encephalopathies.

Guerrini R, Pellock JM.

Handb Clin Neurol. 2012;107:179-93. doi: 10.1016/B978-0-444-52898-8.00011-2. Review. No abstract available.

PMID:
22938971
24.

MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study.

Shinnar S, Bello JA, Chan S, Hesdorffer DC, Lewis DV, Macfall J, Pellock JM, Nordli DR, Frank LM, Moshe SL, Gomes W, Shinnar RC, Sun S; FEBSTAT Study Team.

Neurology. 2012 Aug 28;79(9):871-7. Epub 2012 Jul 25.

25.

Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents.

Wheless JW, Gibson PA, Rosbeck KL, Hardin M, O'Dell C, Whittemore V, Pellock JM.

BMC Pediatr. 2012 Jul 25;12:108. doi: 10.1186/1471-2431-12-108. Review.

26.

Design and phenomenology of the FEBSTAT study.

Hesdorffer DC, Shinnar S, Lewis DV, Moshé SL, Nordli DR Jr, Pellock JM, MacFall J, Shinnar RC, Masur D, Frank LM, Epstein LG, Litherland C, Seinfeld S, Bello JA, Chan S, Bagiella E, Sun S; FEBSTAT study team.

Epilepsia. 2012 Sep;53(9):1471-80. doi: 10.1111/j.1528-1167.2012.03567.x. Epub 2012 Jun 28.

27.

Balancing clinical benefits of vigabatrin with its associated risk of vision loss.

Pellock JM.

Acta Neurol Scand Suppl. 2011;(192):83-91. doi: 10.1111/j.1600-0404.2011.01603.x. Review.

PMID:
22061183
28.

Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations.

Shields WD, Pellock JM.

Acta Neurol Scand Suppl. 2011;(192):1-4. doi: 10.1111/j.1600-0404.2011.01606.x. No abstract available.

PMID:
22061175
29.

Registry initiated to characterize vision loss associated with vigabatrin therapy.

Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, Foroozan R, Wesche DL, Weinberg MA.

Epilepsy Behav. 2011 Dec;22(4):710-7. doi: 10.1016/j.yebeh.2011.08.034. Epub 2011 Oct 5.

PMID:
21978471
30.

Importance of genetic factors in the occurrence of epilepsy syndrome type: a twin study.

Corey LA, Pellock JM, Kjeldsen MJ, Nakken KO.

Epilepsy Res. 2011 Nov;97(1-2):103-11. doi: 10.1016/j.eplepsyres.2011.07.018. Epub 2011 Aug 31.

31.

Infantile spasms: a U.S. consensus report.

Pellock JM, Hrachovy R, Shinnar S, Baram TZ, Bettis D, Dlugos DJ, Gaillard WD, Gibson PA, Holmes GL, Nordl DR, O'Dell C, Shields WD, Trevathan E, Wheless JW.

Epilepsia. 2010 Oct;51(10):2175-89. doi: 10.1111/j.1528-1167.2010.02657.x. Review.

32.

Vigabatrin: 2008 update.

Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.

Epilepsia. 2009 Feb;50(2):163-73. Review.

33.

The accuracy of self-reported history of seizures in Danish, Norwegian and U.S. twins.

Corey LA, Kjeldsen MJ, Solaas MH, Nakken KO, Friis ML, Pellock JM.

Epilepsy Res. 2009 Mar;84(1):1-5. doi: 10.1016/j.eplepsyres.2008.11.014. Epub 2009 Jan 6.

34.

Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.

Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, Genton P, Guerrini R, Kluger G, Pellock JM, Perucca E, Wheless JW.

Lancet Neurol. 2009 Jan;8(1):82-93. doi: 10.1016/S1474-4422(08)70292-8. Review.

PMID:
19081517
35.

The occurrence and characteristics of auras in a large epilepsy cohort.

Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA.

Acta Neurol Scand. 2009 Feb;119(2):88-93. doi: 10.1111/j.1600-0404.2008.01069.x. Epub 2008 Jul 13.

PMID:
18638041
36.

Phenomenology of prolonged febrile seizures: results of the FEBSTAT study.

Shinnar S, Hesdorffer DC, Nordli DR Jr, Pellock JM, O'Dell C, Lewis DV, Frank LM, Moshé SL, Epstein LG, Marmarou A, Bagiella E; FEBSTAT Study Team.

Neurology. 2008 Jul 15;71(3):170-6. doi: 10.1212/01.wnl.0000310774.01185.97. Epub 2008 Jun 4.

PMID:
18525033
37.

Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.

Shinnar S, Pellock JM, Conry JA.

Eur J Paediatr Neurol. 2009 Jan;13(1):3-9. doi: 10.1016/j.ejpn.2008.01.004. Epub 2008 Mar 14.

PMID:
18343174
38.

New developments in the treatment of epilepsy.

Pellock JM, Montouris GD, Ramsay RE.

CNS Spectr. 2000 Apr;5(4 Suppl 2):1-8.

PMID:
18277339
39.

Conclusion: having a plan to manage seizure emergencies.

Pellock JM, Shinnar S.

J Child Neurol. 2007 May;22(5 Suppl):71S-73S. No abstract available.

PMID:
17690090
40.

Overview: definitions and classifications of seizure emergencies.

Pellock JM.

J Child Neurol. 2007 May;22(5 Suppl):9S-13S. Review.

PMID:
17690082
41.

Safety of rapid intravenous valproate infusion in pediatric patients.

Morton LD, O'Hara KA, Coots BP, Pellock JM.

Pediatr Neurol. 2007 Feb;36(2):81-3.

PMID:
17275657
42.

Felbamate: consensus of current clinical experience.

Pellock JM, Faught E, Leppik IE, Shinnar S, Zupanc ML.

Epilepsy Res. 2006 Oct;71(2-3):89-101. Epub 2006 Aug 4. Review.

PMID:
16889941
43.

Analyzing the etiology of benign rolandic epilepsy: a multicenter twin collaboration.

Vadlamudi L, Kjeldsen MJ, Corey LA, Solaas MH, Friis ML, Pellock JM, Nakken KO, Milne RL, Scheffer IE, Harvey AS, Hopper JL, Berkovic SF.

Epilepsia. 2006 Mar;47(3):550-5.

44.

The trials and tribulations of pediatric drug trials.

Shinnar S, Pellock JM.

Neurology. 2005 Nov 8;65(9):1348-9. No abstract available.

PMID:
16275818
45.

Myoclonic epilepsies: syndromes and their treatment.

Pellock JM.

Suppl Clin Neurophysiol. 2004;57:425-32. Review. No abstract available.

PMID:
16106642
46.

Respiratory adverse events associated with diazepam rectal gel.

Pellock JM, Shinnar S.

Neurology. 2005 May 24;64(10):1768-70.

PMID:
15911807
47.

Genetic factors in seizures: a population-based study of 47,626 US, Norwegian and Danish twin pairs.

Kjeldsen MJ, Corey LA, Solaas MH, Friis ML, Harris JR, Kyvik KO, Christensen K, Pellock JM.

Twin Res Hum Genet. 2005 Apr;8(2):138-47.

PMID:
15901477
48.

Zonisamide: physician and patient experiences.

Marmarou A, Pellock JM.

Epilepsy Res. 2005 Mar-Apr;64(1-2):63-9.

PMID:
15869867
49.

Extended-release divalproex in child and adolescent outpatients with epilepsy.

Kernitsky L, O'Hara KA, Jiang P, Pellock JM.

Epilepsia. 2005 Mar;46(3):440-3.

50.

Which seizure-precipitating factors do patients with epilepsy most frequently report?

Nakken KO, Solaas MH, Kjeldsen MJ, Friis ML, Pellock JM, Corey LA.

Epilepsy Behav. 2005 Feb;6(1):85-9.

PMID:
15652738

Supplemental Content

Loading ...
Support Center